Jynarque
Ended Awarded Last action
- Contract number
- 36C26124N0698
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $151,031
Award facts
- Contract value 100% obligated
- $151,031.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$48,975 | |
| Original award | $200,006 |
About this award
Otsuka America Pharmaceutical Inc. received a delivery order award from the Department of Veterans Affairs Veterans Integrated Service Network 21 on June 5, 2024, with a ceiling value of $151,031.04 for the supply of Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This firm-fixed price delivery order is issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation, reflecting the contractor's status as an established large pharmaceutical manufacturer. The contract has an ultimate completion date of August 5, 2024, with performance taking place in Potomac, Maryland.
This delivery order is issued pursuant to Otsuka's substantial Indefinite Delivery Vehicles with the VA, including an $83.3 million Blanket Purchase Agreement for Jynarque awarded by the National Acquisition Center and a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products. These standing agreements enable the VA's Veterans Health Administration to efficiently procure critical specialty medications across multiple Integrated Service Networks to support its healthcare mission for veterans nationwide. The delivery order fulfills the VA's need for this essential pharmaceutical treatment to serve the veteran population.
Quick answers
Who was awarded contract 36C26124N0698?
36C26124N0698 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on June 5, 2024.
How much is contract 36C26124N0698 worth?
The government has obligated $151,031 on 36C26124N0698.
Is contract 36C26124N0698 an order under another contract?
Yes. 36C26124N0698 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0698 competed?
The extent of competition for 36C26124N0698 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award